Difficulty: Medium
Average Score: 87%
Practice
Long-acting beta-agonists (LTBAs) received a Black Box Warning from the U.S. Food and Drug Administration due to the:
Correct answer
C
Rationale
The FDA Black Box Warning for LTBAs highlights increased asthma-related mortality risk, not dermatologic , cardiac , or electrolyte issues.